137 related articles for article (PubMed ID: 11990327)
1. Thymosin alpha in the treatment of chronic hepatitis B: an uncontrolled open-label trial.
Amarapurkar D; Das HS
Indian J Gastroenterol; 2002; 21(2):59-61. PubMed ID: 11990327
[TBL] [Abstract][Full Text] [Related]
2. A randomized, controlled study of thymosin-alpha1 therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis B.
Zavaglia C; Severini R; Tinelli C; Franzone JS; Airoldi A; Tempini S; Bettale G; Ideo G
Dig Dis Sci; 2000 Apr; 45(4):690-6. PubMed ID: 10759236
[TBL] [Abstract][Full Text] [Related]
3. Treatment of chronic hepatitis B: case selection and duration of therapy.
Leung N
J Gastroenterol Hepatol; 2002 Apr; 17(4):409-14. PubMed ID: 11982721
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of thymosin alpha-1 and interferon alpha in treatment of chronic viral hepatitis B: a randomized controlled study.
You J; Zhuang L; Cheng HY; Yan SM; Yu L; Huang JH; Tang BZ; Huang ML; Ma YL; Chongsuvivatwong V; Sriplung H; Geater A; Qiao YW; Wu RX
World J Gastroenterol; 2006 Nov; 12(41):6715-21. PubMed ID: 17075991
[TBL] [Abstract][Full Text] [Related]
5. A randomized, controlled, clinical study of thymosin alpha-1 versus interferon-alpha in [corrected] patients with chronic hepatitis B lacking HBeAg in China [corrected].
You J; Zhuang L; Cheng HY; Yan SM; Qiao YW; Huang JH; Tang BZ; Ma YL; Wu GB; Qu JY; Wu RX
J Chin Med Assoc; 2005 Feb; 68(2):65-72. PubMed ID: 15759817
[TBL] [Abstract][Full Text] [Related]
6. Combination thymosin-alpha 1 and interferon-alpha 2b in the treatment of anti-HBe-positive chronic hepatitis B in Turkey.
Saruc M; Yuceyar H; Kucukmetin N; Demir MA; Kandiloglu AR
Hepatogastroenterology; 2002; 49(45):798-802. PubMed ID: 12063993
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of thymosin α-1 plus peginterferon α-2a combination therapy compared with peginterferon α-2a monotherapy in HBeAg-positive chronic hepatitis B: a prospective, multicenter, randomized, open-label study.
Kim BH; Lee YJ; Kim W; Yoon JH; Jung EU; Park SJ; Kim YJ; Lee HS
Scand J Gastroenterol; 2012 Sep; 47(8-9):1048-55. PubMed ID: 22726105
[TBL] [Abstract][Full Text] [Related]
8. Thymalfasin (thymosin-alpha 1) therapy in patients with chronic hepatitis B.
Liaw YF
J Gastroenterol Hepatol; 2004 Dec; 19(12):S73-5. PubMed ID: 15641208
[TBL] [Abstract][Full Text] [Related]
9. Thymosin alpha1 treatment of chronic hepatitis B: results of a phase III multicentre, randomized, double-blind and placebo-controlled study.
Mutchnick MG; Lindsay KL; Schiff ER; Cummings GD; Appelman HD; Peleman RR; Silva M; Roach KC; Simmons F; Milstein S; Gordon SC; Ehrinpreis MN
J Viral Hepat; 1999 Sep; 6(5):397-403. PubMed ID: 10607256
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of thymosin-alpha 1 and interferon alpha-2b combination therapy in patients with hepatitis B e antigen (HBeAg) negative chronic hepatitis B.
Saruc M; Ozden N; Turkel N; Ayhan S; Hock LM; Tuzcuoglu I; Yuceyar H
J Pharm Sci; 2003 Jul; 92(7):1386-95. PubMed ID: 12820143
[TBL] [Abstract][Full Text] [Related]
11. A pilot study of thymosin alpha1 therapy for chronic hepatitis B patients.
Arase Y; Tsubota A; Suzuki Y; Suzuki F; Kobayashi M; Someya T; Akuta N; Hosaka T; Saitoh S; Ikeda K; Kobayashi M; Kumada H
Intern Med; 2003 Oct; 42(10):941-6. PubMed ID: 14606705
[TBL] [Abstract][Full Text] [Related]
12. A randomized, placebo-controlled trial of thymosin-alpha1 and lymphoblastoid interferon for HBeAg-positive chronic hepatitis B.
Lim SG; Wai CT; Lee YM; Dan YY; Sutedja DS; Wee A; Suresh S; Wu YJ; Machin D; Lim CC; Fock KM; Koay E; Bowden S; Locarnini S; Ishaque SM
Antivir Ther; 2006; 11(2):245-53. PubMed ID: 16640105
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the efficacy of thymosin alpha-1 and interferon alpha in the treatment of chronic hepatitis B: a meta-analysis.
Yang YF; Zhao W; Zhong YD; Yang YJ; Shen L; Zhang N; Huang P
Antiviral Res; 2008 Feb; 77(2):136-41. PubMed ID: 18078676
[TBL] [Abstract][Full Text] [Related]
14. Thymosin-alpha1 and famciclovir combination therapy activates T-cell response in patients with chronic hepatitis B virus infection in immune-tolerant phase.
Lau GK; Nanji A; Hou J; Fong DY; Au WS; Yuen ST; Lin M; Kung HF; Lam SK
J Viral Hepat; 2002 Jul; 9(4):280-7. PubMed ID: 12081605
[TBL] [Abstract][Full Text] [Related]
15. Thymosin-alpha 1 plus interferon-alpha for naive patients with chronic hepatitis C: results of a randomized controlled pilot trial.
Andreone P; Gramenzi A; Cursaro C; Felline F; Loggi E; D'Errico A; Spinosa M; Lorenzini S; Biselli M; Bernardi M
J Viral Hepat; 2004 Jan; 11(1):69-73. PubMed ID: 14738560
[TBL] [Abstract][Full Text] [Related]
16. Thymalfasin for the treatment of chronic hepatitis B.
Chien RN; Liaw YF
Expert Rev Anti Infect Ther; 2004 Feb; 2(1):9-16. PubMed ID: 15482167
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and safety of thymosin alpha-1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial.
Iino S; Toyota J; Kumada H; Kiyosawa K; Kakumu S; Sata M; Suzuki H; Martins EB
J Viral Hepat; 2005 May; 12(3):300-6. PubMed ID: 15850471
[TBL] [Abstract][Full Text] [Related]
18. Thymalfasin (thymosin-alpha 1) therapy in patients with chronic hepatitis B.
Liaw YF
J Gastroenterol Hepatol; 2004 Dec; 19 Suppl 6():S73-5. PubMed ID: 15546254
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody--and hepatitis B virus DNA--positive chronic hepatitis B.
Andreone P; Cursaro C; Gramenzi A; Zavagliz C; Rezakovic I; Altomare E; Severini R; Franzone JS; Albano O; Ideo G; Bernardi M; Gasbarrini G
Hepatology; 1996 Oct; 24(4):774-7. PubMed ID: 8855175
[TBL] [Abstract][Full Text] [Related]
20. Use of immunomodulatory therapy (other than interferon) for the treatment of chronic hepatitis B virus infection.
Lau GK
J Gastroenterol Hepatol; 2000 May; 15 Suppl():E46-52. PubMed ID: 10921382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]